Parameter | No recurrence of AF (n = 86) | Recurrence of AF (n = 91) | Total (n = 177) | P |
---|---|---|---|---|
Age (years) | 65 (57–75) | 71 (61–76) | 69 (60–75) | 0.10 |
Male | 53 (61) | 60 (66) | 113 (64) | 0.64 |
APACHE II | 21 (17–26) | 23 (17–29) | 22 (17–28) | 0.28 |
SAPS II | 39 (30–49) | 44 (31–58) | 41 (31–53) | 0.12 |
ICU LOS (days) | 6 (3–12) | 8 (4–16) | 7 (4–13) | 0.05 |
Hospital LOS (days) | 21 (12–46) | 31 (18–70) | 25 (13–58) | 0.09 |
ICU Outcome | Â | Â | Â | 0.83 |
 Died | 10 (12) | 13 (14) | 23 (13) |  |
 Discharged | 75 (87) | 77 (85) | 152 (86) |  |
 Transferred | 1 (1) | 1 (1) | 2 (1) |  |
Hospital Outcome | Â | Â | Â | 0.08 |
 Died | 22 (26) | 25 (27) | 47 (27) |  |
 Discharged Home | 44 (51) | 37 (41) | 81 (46) |  |
 Transferred | 17 (20) | 29 (32) | 46 (26) |  |
 Not recorded | 3 (3) | 0 (0) | 3 (2) |  |
Weight (kg) | 80 (69–100) (n = 79) | 75 (65–90) (n = 87) | 78 (66–95) (n = 166) | 0.15 |
Height (cm) | 170 (165–175) (n = 76) | 170 (162–175) (n = 84) | 170 (162–175) (n = 160) | 0.73 |
Body Mass Index | 28 (25–34) (n = 76) | 26 (24–31) (n = 84) | 28 (24–33) (n = 160) | 0.06 |
Charlson Score | 2 (1–4) | 3 (2–5) | 2 (1–4) | 0.01 |
Concurrent use of digoxin* | 9 (10) | 25 (27) | 34 (19) | 0.004 |
Concurrent use of beta-blockers | 46 (53) | 42 (46) | 88 (50) | 0.37 |